UK-China collaboration on vaccine approach to prevent shingles
King & Wood Mallesons’ cross-border team advised UK-based Vaccitech, a spin-out company from the University of Oxford’s Jenner Institute, one of the oldest and most renowned vaccine research centres in the world, in its collaboration with China-based CanSino Biologics, to develop a new vaccine approach to prevent shingles (herpes zoster).